Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Seoul National University Hospital: Clinical Trials & FDA Approval Profile

Seoul National University Hospital (Global / Institutional) sponsors 76 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 29 active protocols (17 recruiting now), 21 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)4.0%
Median Closed Enrollment vs National (145 pts)39 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Seoul National University Hospital
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)76
Active Pipeline (Recruiting Now)29 (17)
Completed vs Stopped Early21 / 3 (4.0%)
Median Closed Actual Enrollment39 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Seoul National University Hospital
Hospital Research SiteLocationShared Protocols
Seoul National University HospitalSeoul59
Seoul National University Bundang HospitalSeongnam-si, Gyeonggi-do6
Severance HospitalSeoul, Seoul,50-1 Yonsei-ro/Seodaemun-gu3

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Seoul National University Hospital
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT05534087Platform Study of Circulating Tumor DNA Directed Adjuvant Chemotherapy in Colon Cancer (KCSG CO22-12)Phase IIIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Seoul National University Hospital Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI